Can Conventional ECG Technology Capture Fetal Cardiac Activity?
Recruiting
N/A
Interventional Study
Fetal Monitoring
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 55
- Sex
- Female
- Study type
- Interventional
- Purpose
- Device Feasibility
- Participants needed
- 50 (estimated)
- Sponsor
- University of Washington · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a feasibility study for a new application for capturing fetal cardiac activity. The objective of this study is to determine if it is feasible to capture a fetal ECG signal using a Holter ECG device. As comparison we will use a standard Doppler Fetal Heart Rate (FHR) device.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Singleton or twin pregnant women at 32 weeks gestation to full term after routine antepartum testing.
Exclusion Criteria:
* None.
Contacts